These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 215561)

  • 21. [Study on the role of EB virus in carcinogenesis of nasopharyngeal carcinoma by use of in situ hybridization].
    Zong YS
    Zhonghua Bing Li Xue Za Zhi; 1993 Dec; 22(6):330-2. PubMed ID: 8033275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between undifferentiated nasopharyngeal carcinoma and Epstein-Barr virus shown by correlated nucleic acid hybridization and histopathological studies.
    Andersson-Anvret M; Klein G; Forsby N; Henle W
    IARC Sci Publ (1971); 1978; (20):347-57. PubMed ID: 83285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ detection of Epstein-Barr virus markers in nasopharyngeal carcinoma patients.
    Lung ML; Chan KH; Lam WP; Kou SK; Choy D; Chan CW; Ng MH
    Oncology; 1989; 46(5):310-7. PubMed ID: 2550863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EBV associated malignancies.
    Raab-Traub N; Flynn K; Klein C; Pizza G; De Vinci C; Occhiuzzi L; Farneti G; Caliceti U; Pirodda E
    J Exp Pathol; 1987; 3(4):449-56. PubMed ID: 2842477
    [No Abstract]   [Full Text] [Related]  

  • 25. EB viral genomes in epithelial nasopharyngeal carcinoma cells.
    Wolf H; zur Hausen H; Becker V
    Nat New Biol; 1973 Aug; 244(138):245-7. PubMed ID: 4353684
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration.
    Feinmesser R; Miyazaki I; Cheung R; Freeman JL; Noyek AM; Dosch HM
    N Engl J Med; 1992 Jan; 326(1):17-21. PubMed ID: 1309196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
    Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
    Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients.
    Choi PH; Suen MW; Huang DP; Lo KW; Lee JC
    Cancer; 1993 Nov; 72(10):2873-8. PubMed ID: 8106138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes.
    Tsai ST; Jin YT; Su IJ
    Cancer; 1996 Jan; 77(2):231-6. PubMed ID: 8625228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
    Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
    J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus biomarkers for nasopharyngeal carcinoma in non-endemic regions.
    Gurtsevitch VE; Senyuta NB; Ignatova AV; Lomaya MV; Kondratova VN; Pavlovskaya AI; Dushenkina TE; Maximovich DM; Smirnova KV; Mudunov AM; Lichtenstein AV
    J Gen Virol; 2017 Aug; 98(8):2118-2127. PubMed ID: 28786806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study on nucleic acid hybridization of human nasopharyngeal carcinoma with EBV-W fragment probe].
    Huang GQ; Li Y; Liu YH; Song Y; Xiao YK; Cao JX; Jiang JQ; Hu LF; Sun DT; Yao J
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Dec; 17(4):269-72. PubMed ID: 3032764
    [No Abstract]   [Full Text] [Related]  

  • 35. A 3q+ marker chromosome in EBV-carrying nasopharyngeal carcinomas.
    Mitelman F; Mark-Vendel E; Mineur A; Giovanella B; Klein G
    Int J Cancer; 1983 Dec; 32(6):651-5. PubMed ID: 6317575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus and nasopharyngeal carcinoma.
    Raab-Traub N
    Semin Cancer Biol; 1992 Oct; 3(5):297-307. PubMed ID: 1335793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China.
    Chen H; Chen S; Lu J; Wang X; Li J; Li L; Fu J; Scheper T; Meyer W; Peng YH; Liu W
    Cancer Prev Res (Phila); 2017 Sep; 10(9):542-550. PubMed ID: 28754665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis.
    Bornkamm GW; Stein H; Lennert K; Rüggeberg F; Bartels H; zur Hausen H
    Int J Cancer; 1976 Feb; 17(2):177-81. PubMed ID: 175027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
    Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
    Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.
    Raab-Traub N; Flynn K; Pearson G; Huang A; Levine P; Lanier A; Pagano J
    Int J Cancer; 1987 Jan; 39(1):25-9. PubMed ID: 3025109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.